Speeding the development of new therapies and diagnostics for glaucoma patients

New Horizons ForumAgenda at a Glance

Friday, February 1, 2019Palace Hotel, San Francisco, CA

Wi-Fi sponsored by Santen, Inc.Network: Palace Meetings Password: santen

Download the mobile meeting app at https://crowd.cc/s/2nnSA

Follow the meeting on Twitter: #Glaucoma360

AGENDA AT A GLANCE

7:30 – 8:00 am REGISTRATION, BREAKFAST AND EXHIBITS

8:00 – 8:06 am WELCOME AND OPENING REMARKS Adrienne L. Graves, PhD and Andrew G. Iwach, MD

Co-Founders and Co-Chairs, Glaucoma 360

8:07 – 8:33 am OPENING KEYNOTE ADDRESS — Drs. Henry and Frederick Sutro Memorial Lecture Glaucoma Genetics: Working Toward a Cure

Speaker Janey L. Wiggs, MD, PhD, Harvard Medical School, Massachusetts Eye and Ear Infirmary

8:34 – 8:36 am MORNING CATALYST Jeffrey Liebmann, MD, Columbia University Medical Center

8:37 – 9:22 amModerators

Panelists

Presenters

SHOW ME THE MONEY: Getting to Go in Early Stage Glaucoma FinancingEmmett Cunningham, Jr., MD, PhD, MPH and Christy Shaffer, PhD George A. Cioffi, MD, Columbia University Medical CenterJane Rady, Glaukos Corporation Tracy M. Valorie, MBA, Bausch + LombJoseph B. Ciolino, MD, Harvard Medical School, Massachusetts Eye and Ear/Schepens Eye Research Institute John Freshley, ONL Therapeutics, Inc. James Blaha, Vivid Vision, Inc.

9:23 – 10:21 amModerators Presenting Companies

Panelists

NEW HORIZONS IN DEVICES: New Solutions to Old Problems Malik Kahook, MD and Thomas W. Samuelson, MDBELKIN Laser Ltd., Daria Lemann-Blumenthal, LLB, EMBAImplandata Ophthalmic Products GmbH, Max OstermeierIv antis, Inc., Brett A. TrauthenMicroOptx, Chris Pulling, MSNew World Medical, Rafael ChanQur a, Inc., Douglas Adams

Bryan S. Lee, MD, JD and Arsham Sheybani, MD

10:22 – 10:52 am BREAK, EXHIBITS AND NETWORKING OPPORTUNITY

10:53 – 11:30 amModerators

Featuring

INDUSTRY PANEL DISCUSSION: Glaucoma Devices Arsham Sheybani, MD and Mildred M.G. Olivier, MD

Allergan, Ramin ValianGlauk os Corporation, Jane Rady

Heidelberg Engineering, Kfir Azoulay, MBA Johnson & Johnson Surgical Vision Inc., Nicholas Tarantino, OD

New W orld Medical, Rafael Chan Santen, Inc., Omar Sadruddin, MD Carl Zeiss Meditec, Inc., Angelo Rago

11:31 – 12:15 pm NEW HORIZONS IN VISION RESTORATION: Innovations in Regenerative Ophthalmology Moderators David J. Calkins, PhD and Joel S. Schuman, MD, FACS Presenters Adriana di Polo, PhD, Université de Montréal

Yiqin Du, MD, PhD, University of Pittsburgh School of Medicine and the Louis J. Fox Center for Vision RestorationKarl Kador, PhD, University of Missouri – Kansas City, School of Medicine Kenneth Mandell, MD, PhD, Neurotech Pharmaceuticals, Inc. Jeffrey L. Goldberg, MD, PhD, Byers Eye Institute, Stanford University

12:16 – 1:18 pm NETWORKING BUFFET LUNCHEON

1:19 – 1:21 pm AFTERNOON CATALYST Ruth D. Williams, MD, Wheaton Eye Clinic

1:22 – 2:02 pm NEW HORIZONS IN DRUGS AND DROPS Moderators Robert D. Fechtner, MD and Neeru Gupta, MD, PhD, MBA Presenting Aerpio Pharmaceuticals, Steve Pakola, MD Companies Galimedix Therapeutics, Inc., Hermann Russ, MD, PhD

Nemus Bioscience Inc., Brian Murphy, MD, CEO Nicox Ophthalmics, Inc., Tomas Navratil, PhD

2:03 – 2:28 pm INDUSTRY PANEL DISCUSSION: Drugs and Drops Moderators George A. Cioffi, MD and Steven Mansberger, MD, MPH

Featuring Aerie Pharmaceuticals, Inc., Thomas A. Mitro Bausch + Lomb, Tracy M. Valorie, MBA Santen, Inc., Ellie Chabi, MD

2:29 – 3:04 pm THE FDA AND INDUSTRY: Teamwork to Promote InnovationModerators Reay H. Brown, MD and Kuldev Singh, MD, MPH

Panelists Wiley A Chambers, MD, Deputy Director, Division of Transplant & Ophthalmology Products, Center for Drug Evaluation & Research, FDA Tieuvi Nguyen, PhD, Chief, Intraocular and Corneal Transplants Branch, Center for Devices and Radiological Health, Office of Device Evaluation, FDAThomas W. Samuelson, MD, Minnesota Eye Consultants; President, ASCRS

3:05 – 3:35 pm BREAK, EXHIBITS AND NETWORKING OPPORTUNITY

3:36 – 4:28 pm NEW HORIZONS IN DELIVERY AND DESIGN Moderators Eydie G. Miller-Ellis, MD and Devesh K. Varma, BEng, MD, FRCSC Presenting Allergan, Michael R. Robinson, MDCompanies Eyenovia, Inc., Michael Rowe

Glaukos Corporation, L. Jay Katz, MD Graybug Vision, Inc., Charles P. Semba, MD, FACC, FACR Eximore, Yaniv Barkana, MD Mati Therapeutics, Inc., Christopher Muller Ocular Therapeutix, Jamie L. Hart, MS, MPH Otero Therapeutics, Joel S. Schuman, MD, FACS

4:29 – 5:11 pm TELEMEDICINE: Promising Future for Glaucoma Management Moderators Lama Al-Aswad, MD, MPH and Felipe A. Medeiros, MD, PhDPresenters Michael F. Chiang, MD, Casey Eye Institute, Oregon Health & Science University

Alberto González García, Olleyes, Inc. Khizer Khaderi, MD, MPH, Vizzario, Inc.

5:12 – 5:21 pm FORUM SUMMATION: Eydie G. Miller-Ellis, MD, Scheie Eye Institute, University of Pennsylvania

5:22 – 5:30 pm CLOSING REMARKS: Adrienne L. Graves, PhD and Andrew G. Iwach, MD

5:31 – 7:00 pm RECEPTION, EXHIBITS AND NETWORKING OPPORTUNITY

Follow the meeting on Twitter: #Glaucoma360

Glaucoma Research Foundation thanks the following sponsors for their generous support of Glaucoma 360

PLATINUM

GOLD

BRONZE

Akorn, Inc.Aerpio Therapeutics, Inc.

EllexHaag-Streit USAIcare USA, Inc.

IRIDEX Corporation

Optos, Inc.Optovue, Inc.

Quantel Medical Sight Sciences, Inc.

Smartlens, Inc. Sun Pharmaceutical Industries, Inc.

Lumenis VisionMobius Therapeutics, LLC

Neurotech Pharmaceuticals, Inc. Nidek Inc.

Omeros CorporationOphthalmic Mutual Insurance Company

SILVER

251 Post Street, Suite 600, San Francisco, CA 94108 • 415-986-3162 • www.glaucoma.org